logo
Twitter
Discord
Email
logo
BioHarvest Sciences Inc. Common Stock

BioHarvest Sciences Inc. Common Stock

NASDAQ•BHST
CEO: Dr. Zaki Rakib Ph.D.
Sector: Basic Materials
Industry: Agricultural Inputs
Listing Date: 2021-01-08
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Contact Information
1140-625 Howe Street, Vancouver, BC, V6C 2T6, Canada
604-622-1186
www.bioharvest.com
Market Cap
$84.93M
P/E (TTM)
-7.2
0.2
Dividend Yield
--
52W High
$12.80
52W Low
$4.72
52W Range
2%
Rank72Top 99.7%
0.9
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Weak • 0.9 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2016-2025

Financial Dashboard

Q3 2025 Data

Revenue

$9.07M+38.66%
4-Quarter Trend

EPS

-$0.14-12.50%
4-Quarter Trend

FCF

-$2.54M+11.92%
4-Quarter Trend

2024 Annual Earnings Highlights

Key Highlights

Annual Report Filed Form 40-F filed for fiscal year ended December 31, 2024, confirming compliance with all required filing requirements.
Common Share Count Total outstanding common shares reported as 17,327,716 as of period close, with securities listed on NASDAQ.
Governance Compliance Confirmed Board adopted Code of Ethics; no amendments or waivers occurred during the most recently completed financial year.

Risk Factors

Cash Flow Concerns Company faces negative operating cash flow, raising going concern uncertainty; additional capital requirements are explicitly noted.
Israel Operational Risks Potential political, economic, and military instability in Israel impacts principal business location, facilities, and employees.
Intellectual Property Exposure Risks include potential intellectual property claims, patent infringement challenges, and protection enforcement for company assets.

Outlook

Facility Construction Timeline Focus remains on completion timeline for Yavne No. 2 Manufacturing Facility and R&D Facility development plans.
Product Commercialization Strategy Plans include developing and commercializing future products, product lines, and expanding CDMO services business unit revenue.
Capital Retention Policy Intention to retain all future earnings and cash resources for future development; no cash dividends planned.

Peer Comparison

Revenue (TTM)

Mercer International Inc.MERC
$1.91B
-5.8%
Lavoro LimitedLVRO
$1.75B
-3.7%
American Vanguard CorporationAVD
$530.07M
-4.3%

Gross Margin (Latest Quarter)

BioHarvest Sciences Inc. Common StockBHST
61.4%
+4.6pp
Vox Royalty Corp.VOXR
60.2%
-17.5pp
American Vanguard CorporationAVD
28.7%
+14.1pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
VOXR$252.83M-165.1-2.7%9.5%
SMID$194.47M16.525.0%5.5%
MERC$186.88M-1.1-41.2%68.5%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
7.6%
Steady Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
0%
Cash Flow Needs Attention

Research & Insights

Next earnings:Mar 30, 2026
|
EPS:-$0.08
|
Revenue:-
Reports
All Years

  • Form 40-F - FY 2024

    Period End: Dec 31, 2024|Filed: Mar 31, 2025|
    Revenue: $25.19M+98.8%
    |
    EPS: $-0.80+14.0%
    Miss